Stay updated with breaking news from Affimed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a report released on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Other analysts also recently issued reports about the stock. Truist Financial cut their price objective on shares of Affimed from $8.00 to $6.00 and set a […]
Analysts’ new coverage for Saturday, December 9th: StockNews.com started coverage on shares of Affimed (NASDAQ:AFMD). StockNews.com issued a sell rating on the stock. StockNews.com initiated coverage on shares of Air T (NASDAQ:AIRT). The firm issued a hold rating on the stock. StockNews.com began coverage on shares of American National Bankshares (NASDAQ:AMNB). StockNews.com issued a sell […]
Affimed (NASDAQ:AFMD – Get Free Report) has been given an average rating of “Moderate Buy” by the eight brokerages that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target price among analysts that have […]
Affimed N.V. (NASDAQ:AFMD) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good day, everyone, and welcome to Affimed N.V. Third Quarter 2023 Earnings and Business Update Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there’ll be a question-and-answer session. [Operator Instructions]. Please be advised that today’s […]
StockNews.com began coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a research report report published on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Several other research firms have also commented on AFMD. HC Wainwright reiterated a buy rating and issued a $5.00 target price on shares of Affimed […]